These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24220800)

  • 1. The NLRP3 inflammasome and diabetic cardiomyopathy : editorial to: "Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model" by Beibei Luo et al.
    Singh LP
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):5-6. PubMed ID: 24220800
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3, a potential therapeutic target for type 2 diabetes?
    Liu SS; Ding Y; Lou JQ
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):391-2. PubMed ID: 24867817
    [No Abstract]   [Full Text] [Related]  

  • 4. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
    Satoh M; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
    Ma YX; Li WH; Xie Q
    Pharmazie; 2013 May; 68(5):355-8. PubMed ID: 23802433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and glycaemic control--a cause for concern?
    Hitman GA
    Diabet Med; 2012 May; 29(5):557. PubMed ID: 22506936
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins ameliorate glomerular permeability changes in streptozotocin-induced diabetic rats.
    Mooradian AD; Haas MJ
    Am J Ther; 2007; 14(1):41-5. PubMed ID: 17303974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin inhibits the activation of the nucleotide-binding domain and the leucine-rich, repeat-containing family, pyrin-containing 3 (NLRP3) inflammasome and ameliorates insulin resistance in severely burned rats.
    Chi Y; Chai J; Xu C; Luo H; Zhang Q
    Surgery; 2015 Jun; 157(6):1142-52. PubMed ID: 25817096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
    CAI W; FANG J; CHEN ZY; LIN YL; WU LM; CHEN LL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):814-8. PubMed ID: 21092651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).
    ter Avest E; Abbink EJ; Holewijn S; de Graaf J; Tack CJ; Stalenhoef AF
    Curr Med Res Opin; 2005 Sep; 21(9):1469-76. PubMed ID: 16197666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRP induces hypertension in animal models: homo sapiens says no.
    Jialal I; Devaraj S; Siegel D
    Hypertens Res; 2011 Jul; 34(7):801-2. PubMed ID: 21593738
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of statins on glucose metabolism--a matter of debate.
    Anagnostis P; Athyros VG; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2011 Jun; 107(12):1866. PubMed ID: 21640222
    [No Abstract]   [Full Text] [Related]  

  • 15. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
    Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
    Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats.
    Wang T; Zhao J; Zhang J; Mei J; Shao M; Pan Y; Yang W; Jiang Y; Liu F; Jia W
    J Diabetes; 2018 Jul; 10(7):556-563. PubMed ID: 29171721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin restores advanced glycation end product-induced decrease in sirtuin 1 (SIRT1) mRNA levels in THP-1 monocytic cells through its anti-oxidative properties.
    Ishibashi Y; Nakashima S; Matsui T; Yamagishi S
    Int J Cardiol; 2013 Nov; 169(6):e102-3. PubMed ID: 24383118
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosuvastatin suppresses the oxidative response in the venous limb of an arteriovenous fistula and enhances the fistula blood flow in diabetic rats.
    Fang SY; Roan JN; Lin Y; Hsu CH; Chang SW; Huang CC; Tsai YC; Lam CF
    J Vasc Res; 2014; 51(2):81-9. PubMed ID: 24434545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deactivation of the NLRP3 inflammasome in infiltrating macrophages by duodenal-jejunal bypass surgery mediates improvement of beta cell function in type 2 diabetes.
    Wu D; Yan ZB; Cheng YG; Zhong MW; Liu SZ; Zhang GY; Hu SY
    Metabolism; 2018 Apr; 81():1-12. PubMed ID: 29129820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.